81 FR 96021 - Office of the Director; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 250 (December 29, 2016)

Page Range		96021-96022
FR Document		2016-31611

Federal Register, Volume 81 Issue 250 (Thursday, December 29, 2016)

[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Pages 96021-96022]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-31611]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH 
Clinical Center Research Hospital Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The portions of the meeting devoted to the Anonymous Safety Hotline 
and the laboratories or units and staff involved in the individual 
reports to the Hotline, staff, as well as discussions regarding non-
executive employees holding specific positions in the Clinical Center 
will be closed to the public in accordance with the provisions set 
forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as 
amended. Premature disclosure of the laboratories or units and staff 
involved in the individual reports could significantly limit the 
Hotline's purpose by compromising anonymity. Discussion of specific 
non-executive employees would constitute a clearly unwarranted invasion 
of personal privacy.

    Name of Committee: NIH Clinical Center Research Hospital Board.
    Date: January 13, 2017.
    Open: 8:30 a.m. to 12:30 p.m.
    Agenda: Board Chair's Overview, Remarks from the NIH Director 
and the New CEO, Clinical Center Focus Groups, Improving the 
Clinical Center's Census, Clinical Center Patient and Worker Safety 
Metrics.
    Open: 1:30 p.m. to 3:30 p.m.
    Agenda: IT Infrastructure and Security, Audits of Delayed 
Reporting--Self-Audit Results and Formal Audit Planning, Facilities 
Update.
    Closed: 3:45 p.m. to Adjournment.
    Agenda: Anonymous Safety Hotline, Clinical Center Employees.

[[Page 96022]]

    Place: Conference Room 6C6, Building 31, National Institutes of 
Health, Bethesda, MD 20892.
    Contact Person: Gretchen Wood, Staff Assistant, National 
Institutes of Health, Office of the Director, One Center Drive, 
Building 1 Room 126, Bethesda, MD 20892, 301-496-4272, 
[email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: December 23, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31611 Filed 12-28-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices 96021

Dated: December 21, 2016. SUPPLEMENTARY INFORMATION: Pursuant Dated: December 21, 2016.
Joanna Bare, to Section 2101 of the Public Health Bruce Gellin,
Executive Officer, Division of Management Service Act (42 U.S.C. 300aa–1), the Designated Federal Officer, National Vaccine
Services, Center for Scientific Review, NIH. Secretary of Health and Human Services Advisory Committee, Deputy Assistant
[FR Doc. 2016–31543 Filed 12–28–16; 8:45 am] was mandated to establish the National Secretary for Health.
BILLING CODE 4140–01–P Vaccine Program to achieve optimal [FR Doc. 2016–31530 Filed 12–28–16; 8:45 am]
prevention of human infectious diseases BILLING CODE 4150–44–P
through immunization and to achieve
DEPARTMENT OF HEALTH AND optimal prevention against adverse
HUMAN SERVICES reactions to vaccines. The NVAC was DEPARTMENT OF HEALTH AND
established to provide advice and make HUMAN SERVICES
Meeting of the National Vaccine recommendations to the Director of the
Advisory Committee National Vaccine Program on matters National Institutes of Health
AGENCY: National Vaccine Program related to the Program’s responsibilities.
Office of the Director; Notice of
Office, Office of the Assistant Secretary The Assistant Secretary for Health
Meeting
for Health, Office of the Secretary, serves as Director of the National
Department of Health and Human Vaccine Program. Pursuant to section 10(d) of the
Services. During the February 2017 NVAC Federal Advisory Committee Act, as
ACTION: Notice. meeting, there will be a discussion of amended (5 U.S.C. App), notice is
the 21st Century Cures Act and hereby given of a meeting of the NIH
SUMMARY: As stipulated by the Federal vaccines; an update on the recent Clinical Center Research Hospital
Advisory Committee Act, the mumps outbreaks in the US; Board.
Department of Health and Human presentations on Zika virus disease and
Services (HHS) is hereby giving notice The meeting will be open to the
the status of Zika vaccine development; public as indicated below, with
that a meeting is scheduled to be held presentations on vaccine adverse events
for the National Vaccine Advisory attendance limited to space available.
and insights from personalized Individuals who plan to attend and
Committee (NVAC). The meeting will be medicine; and the NVAC’s Mid-course
open to the public; public comment need special assistance, such as sign
Review Working Group will present its language interpretation or other
sessions will be held during the findings and draft recommendations for
meeting. reasonable accommodations, should
deliberation and vote by the Committee. notify the Contact Person listed below
DATES: The meeting will be held on Please note that agenda items are subject in advance of the meeting.
February 7 and 8, 2017. The meeting to change as priorities dictate.
times and agenda will be posted on the Information on the final meeting agenda The portions of the meeting devoted
NVAC Web site at http://www.hhs.gov/ will be posted prior to the meeting on to the Anonymous Safety Hotline and
nvpo/nvac/meetings/index.html as soon the NVAC Web site: http:// the laboratories or units and staff
as they become available. www.hhs.gov/nvpo/nvac/index.html. involved in the individual reports to the
Hotline, staff, as well as discussions
ADDRESSES: Pre-registration is required Public attendance at the meeting is regarding non-executive employees
for members of the public who wish to limited to the available space. holding specific positions in the
attend the meeting and who wish to Individuals who plan to attend in Clinical Center will be closed to the
participate in the public comment person and need special assistance, public in accordance with the
session. Individuals who wish to attend such as sign language interpretation or provisions set forth in section
the meeting and/or participate in the other reasonable accommodations, 552b(c)(9)(B) and 552b(c)(6), Title 5
public comment session should register should notify the National Vaccine U.S.C., as amended. Premature
at http://www.hhs.gov/nvpo/nvac/ Program Office at the address/phone disclosure of the laboratories or units
meetings/index.html. Participants may listed above at least one week prior to and staff involved in the individual
also register by emailing nvpo@hhs.gov the meeting. For those unable to attend reports could significantly limit the
or by calling (202) 690–5566 and in person, a live webcast will be Hotline’s purpose by compromising
providing their name, organization, and available. More information on anonymity. Discussion of specific non-
email address. registration and accessing the webcast executive employees would constitute a
U.S. Department of Health and Human can be found at http://www.hhs.gov/ clearly unwarranted invasion of
Services, Hubert H. Humphrey nvpo/nvac/meetings/index.html. personal privacy.
Building, Great Hall, 200 Members of the public will have the
Independence Avenue SW., Name of Committee: NIH Clinical Center
opportunity to provide comments at the Research Hospital Board.
Washington, DC 20201. NVAC meeting during the public Date: January 13, 2017.
The meeting can also be accessed comment periods designated on the Open: 8:30 a.m. to 12:30 p.m.
through a live webcast on both days of agenda. Public comments made during Agenda: Board Chair’s Overview, Remarks
the meeting. For more information, visit the meeting will be limited to three from the NIH Director and the New CEO,
http://www.hhs.gov/nvpo/nvac/ minutes per person to ensure time is Clinical Center Focus Groups, Improving the
meetings/index.html. allotted for all those wishing to speak. Clinical Center’s Census, Clinical Center
asabaliauskas on DSK3SPTVN1PROD with NOTICES

FOR FURTHER INFORMATION CONTACT: Individuals are also welcome to submit Patient and Worker Safety Metrics.
National Vaccine Program Office, U.S. their written comments. Written Open: 1:30 p.m. to 3:30 p.m.
Agenda: IT Infrastructure and Security,
Department of Health and Human comments should not exceed three
Audits of Delayed Reporting—Self-Audit
Services, Room 715H, Hubert H. pages in length. Individuals submitting Results and Formal Audit Planning, Facilities
Humphrey Building, 200 Independence written comments should email their Update.
Avenue SW., Washington, DC 20201. comments to the National Vaccine Closed: 3:45 p.m. to Adjournment.
Phone: (202) 690–5566; email: nvpo@ Program Office (nvpo@hhs.gov) at least Agenda: Anonymous Safety Hotline,
hhs.gov. five business days prior to the meeting. Clinical Center Employees.

VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1

Document Created: 2016-12-29 01:58:56
Document Modified: 2016-12-29 01:58:56

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 13, 2017.
FR Citation		81 FR 96021

81 FR 96021 - Office of the Director; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 250 (December 29, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health